Colgate-Palmolive is projected to report Q2 2026 revenue of $5.26 billion and EPS of $0.95, with the current stock price of $102.45 trading at a discount to the average analyst price target of $108.50.
Investors are primarily focused on organic sales growth, specifically whether volume-led gains can sustain momentum as the company laps significant pricing actions from the prior year.
Management’s ability to expand gross margins through productivity initiatives and stabilizing raw material costs remains a central theme for the quarter. Additionally, analysts are looking for continued recovery and capacity expansion within the Hill’s Pet Nutrition segment following recent supply chain investments.